Month: May 2022
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.
-
Memorial Day, 2022
We’ll resume our editorial posting tomorrow.
-
Infographic – Emerging U.S. Tech Hubs
Since the beginning of 2021, venture capital investments in tech companies are gaining in Austin and Dallas, and the number of deals is also on the rise in Miami.
-
Grant Funds Epilepsy Stem Cell Therapy Trial
A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy.
-
Biobank Study to Assess Obesity Types, Genetics
A study is now enrolling individuals to better understand different types of obesity, as well as genetics and other factors behind various obesity conditions.
-
High Speed Genetics Tech Start-Up Raises $15M
A start-up enterprise developing a high-performance genomic screening and detection technology is raising $15 million in early financing.
-
AI Drug Company Creating Covid-19 Therapy for Rapid Delivery
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced.
-
Trial Shows Therapy Controls Gut Disorder with Healthy Microbes
Results from a clinical trial show a microbiome treatment produces healthy gut microbes that reduce recurrences of C. difficile infections.
-
Infographic – 100 Promising AI Companies
CB Insights now compiles an annual list of new companies creating A.I. applications and tools, with the 2022 collection published this week.
-
Addiction Therapy, VR Companies Partner on Veteran PTSD
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder.